BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29420980)

  • 1. MR Imaging for Prostate Cancer Screening and Active Surveillance.
    Druskin SC; Macura KJ
    Radiol Clin North Am; 2018 Mar; 56(2):251-261. PubMed ID: 29420980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pragmatic Approach to Prostate Cancer Screening.
    Tosoian JJ; Penson DF; Chinnaiyan AM
    JAMA; 2024 May; 331(17):1448-1450. PubMed ID: 38581253
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for active surveillance for low risk prostate cancer.
    Drost FH; Roobol MJ
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):487-489. PubMed ID: 28406334
    [No Abstract]   [Full Text] [Related]  

  • 4. Integration of multiparametric MRI into active surveillance of prostate cancer.
    Holtz JN; Tay KJ; Polascik TJ; Gupta RT
    Future Oncol; 2016 Nov; 12(21):2513-2529. PubMed ID: 27322161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate MR Imaging: An Update.
    Shaish H; Taneja SS; Rosenkrantz AB
    Radiol Clin North Am; 2017 Mar; 55(2):303-320. PubMed ID: 28126217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
    Augustin H; Mayerhofer K; Seles M; Pummer K
    Urol Int; 2015; 95(2):125-31. PubMed ID: 25791432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technique of Multiparametric MR Imaging of the Prostate.
    Purysko AS; Rosenkrantz AB
    Radiol Clin North Am; 2018 Mar; 56(2):211-222. PubMed ID: 29420977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making.
    Duvnjak P; Schulman AA; Holtz JN; Huang J; Polascik TJ; Gupta RT
    Radiol Clin North Am; 2018 Mar; 56(2):239-250. PubMed ID: 29420979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MR imaging of the Prostate: Pitfalls in Interpretation.
    Thomas S; Oto A
    Radiol Clin North Am; 2018 Mar; 56(2):277-287. PubMed ID: 29420982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI and surveillance.
    Ouzzane A; Puech P; Villers A
    Curr Opin Urol; 2012 May; 22(3):231-6. PubMed ID: 22388665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Characteristics of Prostate Cancer Patients Who Discontinued Active Surveillance on 3-T Multiparametric Prostate MRI.
    Habibian DJ; Liu CC; Dao A; Kosinski KE; Katz AE
    AJR Am J Roentgenol; 2017 Mar; 208(3):564-569. PubMed ID: 28075651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging for prostate cancer: what the urologist needs to know.
    Kiechle J; Pahwa S; Gulani V; Kanaan G; Sedelaar J; Ponsky L
    Minerva Urol Nefrol; 2015 Sep; 67(3):201-10. PubMed ID: 26054410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan.
    Mitsuzuka K; Koga H; Sugimoto M; Arai Y; Ohyama C; Kakehi Y; Naito S
    Int J Urol; 2015 Aug; 22(8):754-9. PubMed ID: 25959857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transrectal ultrasonography in prostate cancer.
    Ghai S; Toi A
    Radiol Clin North Am; 2012 Nov; 50(6):1061-73. PubMed ID: 23122038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Prostate MR Imaging in Radiation Oncology.
    Ménard C; Paulson E; Nyholm T; McLaughlin P; Liney G; Dirix P; van der Heide UA
    Radiol Clin North Am; 2018 Mar; 56(2):319-325. PubMed ID: 29420985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric MR imaging of the Prostate: Interpretation Including Prostate Imaging Reporting and Data System Version 2.
    Furlan A; Borhani AA; Westphalen AC
    Radiol Clin North Am; 2018 Mar; 56(2):223-238. PubMed ID: 29420978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer overdiagnosis and overtreatment.
    Klotz L
    Curr Opin Urol; 2012 May; 22(3):203-9. PubMed ID: 22472510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate MRI can reduce overdiagnosis and overtreatment of prostate cancer.
    Rosenkrantz AB; Taneja SS
    Acad Radiol; 2015 Aug; 22(8):1000-6. PubMed ID: 25791578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?
    Tay KJ; Mendez M; Moul JW; Polascik TJ
    Curr Opin Urol; 2015 May; 25(3):185-90. PubMed ID: 25768694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of MRI in prostate cancer active surveillance.
    Johnson LM; Choyke PL; Figg WD; Turkbey B
    Biomed Res Int; 2014; 2014():203906. PubMed ID: 25525592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.